Journal Articles
Shiels, Ryan G., Vidimce, Josif, Pearson, Andrew G., Matthews, Ben, Wagner, Karl-Heinz, Battle, Andrew R., Sakellaris, Harry and Bulmer, Andrew C. (2019). Unprecedented microbial conversion of biliverdin into bilirubin-10-sulfonate. Scientific Reports, 9 (1) 2988. doi: 10.1038/s41598-019-39548-w
Boon, Ai-Ching, Lam, Alfred K., Gopalan, Vinod, Benzie, Iris F., Briskey, David, Coombes, Jeff S., Fassett, Robert G. and Bulmer, Andrew C. (2015). Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure. Scientific Reports, 5 (15482) 15482, 1-16. doi: 10.1038/srep15482
Bulmer, A. C., Coombes, J. S., Blanchfield, J. T., Toth, I., Fassett, R. G. and Taylor, S. M. (2011). Bile pigment phamacokinetics and absorption in the rat: Therapeutic potential for enteral administration. British Journal of Pharmacology, 164 (7), 1857-1870. doi: 10.1111/j.1476-5381.2011.01413.x
Bulmer, Andrew C., Blanchfield, Joanne T., Toth, Istvan, Fassett, Robert G. and Coombes, Jeff S. (2008). Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection. Atherosclerosis, 199 (2), 390-396. doi: 10.1016/j.atherosclerosis.2007.11.022
Morgan, Michael, Bulmer, Andrew C., Woodruff, Trent M., Proctor, Lavinia M., Williams, Hua M., Stocks, Shelli Z., Pollitt, Sandra, Taylor, Stephen M. and Shiels, Ian A (2008). Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration. European Journal of Pharmaceutical Sciences, 33 (4-5), 390-398. doi: 10.1016/j.ejps.2008.01.009
Bulmer, A.C., Blanchfield, J.T., Coombes, J.S. and Toth, I. (2008). In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorganic & Medicinal Chemistry, 16 (7), 3616-3625. doi: 10.1016/j.bmc.2008.02.008
Bulmer, A. C., Coombes, J. S., Sharman, J. E. and Stewart, I. B. (2008). Effects of maximal static apnea on antioxidant defenses in trained free divers. Medicine and Science in Sports and Exercise, 40 (7), 1307-1313. doi: 10.1249/MSS.0b013e31816a7188
Bulmer, A., Ried, K., Blanchfield, J. and Wagner, K. (2008). The anti-mutagenic properties of bile pigments. Mutation Research, 658 (1-2), 28-41. doi: 10.1016/j.mrrev.2007.05.001
Bulmer, A., Ried, K., Coombes, J., Blanchfield, J., Toth, I. and Wagner, K. (2007). The anti-mutagenic and antioxidant effects of bile pigments in the Ames Salmonella test. Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 629 (2), 122-132. doi: 10.1016/j.mrgentox.2007.01.008
Stewart, Ian B., Bulmer, Andrew .C, Sharman, James E. and Ridgway, Lynne (2005). Arterial oxygen desaturation kinetics during apnea. Medicine And Science In Sports And Exercise, 37 (11), 1871-1876. doi: 10.1249/01.mss.0000176305.51360.7e
Bulmer, AC and Coombes, JS (2004). Optimising exercise training in peripheral arterial disease. Sports Medicine, 34 (14), 983-1003. doi: 10.2165/00007256-200434140-00004
Conference Papers
Bulmer, A.C., Coombes, J.S., Blanchfield, J.T., Toth, I. and Taylor, S.M. (2008). Absorption and pharmacokinetics of bilirubin and biliverdin administration in the rat. Australian Health and Medical Research Congress, Brisbane, 16 - 21 November, 2008.
Bulmer, A. C., Blanchfield, J. T., Toth, I., Fassett, R. G. and Coombes, J. S. (2008). Improved resistance to serum oxidation in Gilberts syndrome: a mechanism for cardiovascular protection. The 2008 meeting of the Society for Free Radical Research - Europe (SFRR-E, Berlin, Germany, 5th-9th July 2008. London: Gordon and Breach. doi: 10.1080/10715760802207914
Thesis
Bulmer, Andrew (2008). Efficacy of bile pigment supplementation : in vitro and in vivo considerations. PhD Thesis, School of Human Movement Studies, The University of Queensland. doi: 10.14264/151727